14.09.2010
- U.S. biotech firm Genzyme said it agreed to sell its genetic-testing business to Labcorp of America Holdings for $925 million in cash. Genzyme, which recently rejected a takeover...
13.09.2010
- U.S. biotech company Genzyme has begun laying off an unspecified number of employees, a move it said was unrelated to Sanofi-Aventis' takeover bid. The company did not reveal the...
13.09.2010
- French drugmaker Sanofi-Aventis has put together about $10 billion in loans for its $18.5 billion bid for U.S. biotech company Genzyme, Bloomberg reported on Friday, citing unnamed...
08.09.2010
- Sanofi-Aventis Chief Executive Chris Viehbacher has stepped up his campaign to win Genzyme by meeting shareholders of the U.S. biotech company face to face, the French company said...
07.09.2010
- Glaxosmithkline will not step in as a rival bidder for U.S. biotech Genzyme and take on Sanofi-Aventis, the British drugmaker's head of research and development told a French...
06.09.2010
- French drugmaker Sanofi-Aventis would be prepared to moderately raise its $69 per share offer for Genzyme if the U.S. biotech agreed to negotiate, Dow Jones reported, citing a...
02.09.2010
- U.S. biotech Genzyme, which has rejected an $18.5 billion offer from French drugmaker Sanofi-Aventis, appears to hold the upper hand in the takeover struggle, according to Geoffrey...
02.09.2010
- French oil company Total has received offers for its UK Lindsey refinery and hopes to sell it by the end of the year, Chief Executive Officer Christophe de Margerie, said on...
31.08.2010
- U.S. biotech company Genzyme rejected an $18.5 billion buyout offer from French drugmaker Sanofi-Aventis on Monday, setting the stage for a protracted and potentially hostile...
30.08.2010
- France's Sanofi-Aventis on Sunday publicly disclosed its $18.5 billion, $69-per-share cash offer for Genzyme in a bid to rouse shareholders after failing to engage the U.S...
